|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.82 USD | -6.20% |
|
+0.20% | +21.58% |
| 28/07 | Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target | MT |
| 28/07 | Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target | MT |
| Market Cap | 757M 665M 621M 570M 1.07B 72.53B 1.09B 7.36B 2.88B 35.89B 2.84B 2.78B 124B | P/E 2026 * |
-10.3x | P/E 2027 * | -10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 421M 370M 345M 317M 593M 40.28B 607M 4.09B 1.6B 19.93B 1.58B 1.54B 68.91B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tenax Therapeutics, Inc.
| 1 day | -6.20% | ||
| 1 week | +0.20% | ||
| Current month | +1.86% | ||
| 1 month | +9.78% | ||
| 3 months | +15.96% | ||
| 6 months | +10.85% | ||
| Current year | +21.58% |
| 1 week | 14.22 |  | 16.5 |
| 1 month | 13.22 | | 19.4 |
| Current year | 10.25 | | 19.4 |
| 1 year | 5.78 | | 19.4 |
| 3 years | 2.77 | | 61.2 |
| 5 years | 2.77 | | 3,135.04 |
| 10 years | 2.77 | | 84,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 14/07/2021 | |
Thomas Staab
DFI | Director of Finance/CFO | 58 | 11/05/2026 |
Gillian Andor
CTO | Chief Tech/Sci/R&D Officer | - | 21/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Proehl
CHM | Chairman | 67 | 01/06/2021 |
Stuart Rich
BRD | Director/Board Member | 76 | 25/02/2021 |
June Almenoff
BRD | Director/Board Member | 69 | 25/02/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/7/26 | Fiscal year | Chief Executive Officer | 17,438 | 0.0657% | ||
| 11/5/26 | Other | Chief Financial Officer | 0 | 0% | ||
| 11/5/26 | Free | Chief Financial Officer | 460,000 | 2.6748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.20% | +0.20% | +138.26% | -42.11% | 757M | |
| +0.66% | +6.75% | +0.80% | +14.57% | 48.95B | |
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | |
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | |
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | |
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | |
| -0.94% | +0.05% | - | - | 16.62B | |
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | |
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | |
| +0.20% | +4.02% | +4.09% | +9.91% | 13.56B | |
| Average | -0.59% | +5.23% | +66.54% | +87.18% | 25.39B | |
| Weighted average by Cap. | -0.04% | +6.90% | +72.20% | +122.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -78.35M -68.85M -64.26M -58.98M -110M -7.5B -113M -762M -298M -3.71B -294M -288M -12.84B | -93.6M -82.25M -76.77M -70.46M -132M -8.97B -135M -910M -356M -4.44B -351M -344M -15.34B |
| Net Debt | -337M -296M -276M -253M -474M -32.25B -486M -3.27B -1.28B -15.96B -1.26B -1.24B -55.16B | -1.9M -1.67M -1.56M -1.43M -2.68M -182M -2.74M -18.48M -7.23M -90.06M -7.13M -6.98M -311M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | USD 14.82 | -6.20% | 1,565,528 |
| 28/07/26 | USD 15.80 | -2.41% | 1,560,344 |
| 27/07/26 | USD 16.19 | +11.42% | 1,803,993 |
| 24/07/26 | USD 14.53 | -0.75% | 1,160,153 |
| 23/07/26 | USD 14.64 | -1.01% | 1,400,924 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TENX Stock
Select your edition
All financial news and data tailored to specific country editions
